The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EDSA | -45.57% | -97.86% | -53.65% | -97% |
| S&P | +15.58% | +78.13% | +12.24% | +141% |
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis, a common, potentially debilitating condition and occupational illness. The company was founded on June 12, 2007 and is headquartered in Markham, Canada.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | -$25.87K | 41.5% |
| Market Cap | $17.38M | 20.3% |
| Market Cap / Employee | $1.02M | 0.0% |
| Employees | 17 | 6.3% |
| Net Income | -$2,228.36K | -131.6% |
| EBITDA | -$2,444.38K | -154.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $10.79M | 940.4% |
| Accounts Receivable | $642.87K | 137.3% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $0.00K | -100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -81.65% | 12.8% |
| Return On Invested Capital | -157.59% | -48.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1,765.54K | -79.8% |
| Operating Free Cash Flow | -$1,765.54K | -79.8% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.75 | 6.60 | 2.24 | 3.53 | -29.90% |
| Price to Tangible Book Value | -55.84 | -10.98 | 3.30 | 5.97 | -68.49% |
| Enterprise Value to EBITDA | -2.71 | -5.10 | -5.92 | -6.51 | -53.49% |
| Return on Equity | -150.7% | -58.8% | -69.6% | -99.6% | -27.14% |
| Total Debt | $0.00K | $0.00K | $0.00K | $0.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
